(Q38083565)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Interstitial cystitis/bladder pain syndrome: diagnosis and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

I Offiah

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

B A O'Reilly

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

22 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

International Urogynecology Journal and Pelvic Floor Dysfunction

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1243-1256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23430074%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00192-013-2057-3

24 February 2020

exact match

0 references

cites work

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Bladder Pain Syndrome Committee of the International Consultation on Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

The historical origins of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Interstitial cystitis and painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Interstitial cystitis is an etiology of chronic pelvic pain in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Sites of pain from interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Anterior vaginal wall tenderness (AVWT) as a physical symptom in chronic pelvic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Intravesical lignocaine in the diagnosis of bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Use of the Short-Form McGill Pain Questionnaire as a diagnostic tool in women with chronic pelvic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Receiver operating characteristic curves of symptom scores in the diagnosis of interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Efficiency of questionnaires used to screen for interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Urodynamic testing and interstitial cystitis/painful bladder syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Prevalence of positive potassium sensitivity test which is an indicator of bladder epithelial permeability dysfunction in a fixed group of Turkish women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

The role of cystoscopy in the diagnosis of Hunner's ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Bladder pain syndrome: do the different morphological and cystoscopic features correlate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Interleukin-8 is essential for normal urothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Defective Tamm-Horsfall protein in patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Sexual function and sexual distress in women with interstitial cystitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Childhood maltreatment and migraine (part III). Association with comorbid pain conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Myofascial pain and pelvic floor dysfunction in patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Severity of interstitial cystitis symptoms and quality of life in female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Long-term results of amitriptyline treatment for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Cimetidine in the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: long-term results of a case series in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Treatment of interstitial cystitis with hydrodistention and bladder training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Bladder substitution by ileal neobladder for women with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00192-013-2057-3

Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

12 December 2020

Interstitial cystitis: bladder training with intravesical oxybutynin

1 reference

12 December 2020

Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis?

1 reference

12 December 2020

Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms: a Chinese multi-center study.

1 reference

12 December 2020

Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up

1 reference

12 December 2020

The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis

1 reference

12 December 2020

Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome

1 reference

12 December 2020

A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis

1 reference

12 December 2020

The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: preliminary results

1 reference

12 December 2020

Spousal support decreases the negative impact of pain on mental quality of life in women with interstitial cystitis/painful bladder syndrome.

1 reference

12 December 2020

Prevalence of pelvic floor dysfunction in patients with interstitial cystitis

1 reference

12 December 2020

Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis

1 reference

12 December 2020

Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987

1 reference

12 December 2020

Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis

1 reference

12 December 2020

Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome

1 reference

12 December 2020

A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis

1 reference

12 December 2020

Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium

1 reference

12 December 2020

Validity of Pelvic Pain, Urgency, and Frequency questionnaire in patients with interstitial cystitis/painful bladder syndrome

1 reference

12 December 2020

Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management

1 reference

12 December 2020

Case-control study of medical comorbidities in women with interstitial cystitis

1 reference

12 December 2020

Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain

1 reference

12 December 2020

Increased number of substance P positive nerve fibres in interstitial cystitis

1 reference

12 December 2020

Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland

1 reference

12 December 2020

The significance of potassium chloride sensitivity test and urinary uronic acid level in the diagnosis of chronic pelvic pain syndrome

1 reference

12 December 2020

Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis.

1 reference

12 December 2020

There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally

1 reference

12 December 2020

Incidence and clinical characteristics of interstitial cystitis in the community

1 reference

12 December 2020

Effect of comestibles on symptoms of interstitial cystitis

1 reference

12 December 2020

Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients

1 reference

12 December 2020

Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.

1 reference

12 December 2020

Dilemmas in diagnosing pelvic pain: multiple pelvic surgeries common in women with interstitial cystitis

1 reference

12 December 2020

Increased concentration of neutrophil elastase in urine from patients with interstitial cystitis

1 reference

12 December 2020

Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis

1 reference

12 December 2020

Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients

1 reference

12 December 2020